Canaccord raises target for Illumina stock from USD 205.00 to USD 300.00
Published on 10/20/2026 at 19:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and reporting date
- Canaccord Genuity raised its Illumina target from USD 205.00 to USD 300.00 on October 19, 2026.
- Second-quarter revenue reached USD 1.16 billion, while adjusted earnings per share came to USD 1.31.
- Illumina stock was at EUR 239.50 at Lang & Schwarz on October 20, 2026 at 7:34 p.m. CEST.
Canaccord Genuity raised its price target for Illumina stock from USD 205.00 to USD 300.00 in a note dated October 19, 2026, while keeping a Hold rating, as MarketBeat reported. The target revision is the clearest current analyst marker for the company. Illumina stock was trading at EUR 239.50 at Lang & Schwarz on October 20, 2026 at 7:34 p.m. CEST.
Revenue growth meets earnings demand
Illumina's second-quarter 2026 revenue reached USD 1.16 billion, while earnings per share came to USD 1.31, according to Yahoo Finance. MarketBeat said the quarterly earnings figure exceeded the USD 1.23 consensus estimate, giving the reported result a USD 0.08 per-share advantage over expectations.
The reported revenue also stood above the USD 1.13 billion consensus estimate cited by MarketBeat. That combination leaves the October 29 results date as the next direct test of whether the recent operating recovery is continuing.
Stock position and valuation
On the Nasdaq, Illumina last traded at USD 269.23 on October 20, 2026 at 1:36 p.m. EDT. The same market data place the 52-week range at USD 94.00 to USD 309.35 and the market capitalization at USD 40.7 billion as of October 20, 2026.
The Nasdaq quotation was 13.00 percent below the 52-week high, calculated from USD 269.23 and USD 309.35. Illumina's price-to-earnings ratio was 50.20, while its year-to-date performance stood at 100.26 percent as of October 19, 2026.
What comes next for Illumina
Illumina announced on October 8, 2026 that it will publish third-quarter 2026 results after the market close on October 29, 2026. The company also scheduled its earnings call for 4:30 p.m. Eastern Time that day.
The upcoming report will put the recent figures into a newer period. Investors will have a fresh revenue, earnings and outlook set against the USD 4.60 billion to USD 4.64 billion full-year revenue outlook cited in recent coverage.
Price and next reporting date
Illumina combines a higher analyst target with a scheduled results date less than two weeks away. The Nasdaq quote of USD 269.23 remains below the USD 300.00 Canaccord target, while the euro quotation provides the relevant after-hours view for German investors.
The further course of trading is shown by the continuously updated real-time quote of Illumina stock.
Illumina stock at a glance
- Company: Illumina, Inc.
- ISIN: US4523271090
- Ticker: ILMN
- Primary exchange: Nasdaq
- Price Lang & Schwarz as of October 20, 2026, 7:34 p.m. CEST: EUR 239.50
- Market capitalization: USD 40.7 billion (as of October 20, 2026)
- 52-week range: USD 94.00-309.35 (as of October 20, 2026)
- Sector / Industry: Healthcare / Diagnostics and Research
- Next earnings date: October 29, 2026
Market context: Market report Nasdaq Composite.
